• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性 HCV 感染清除后的免疫逆转——一切重置?

Reversal of Immunity After Clearance of Chronic HCV Infection-All Reset?

机构信息

Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.

Department of Gastroenterology and Hepatology, Essen University Hospital, University of Duisburg-Essen, Essen, Germany.

出版信息

Front Immunol. 2020 Oct 8;11:571166. doi: 10.3389/fimmu.2020.571166. eCollection 2020.

DOI:10.3389/fimmu.2020.571166
PMID:33133084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7578424/
Abstract

Chronic viral infections cause deterioration of our immune system. However, since persistent infections rarely can be eliminated, the reinvigoration capacity of an exhausted immune system has remained largely elusive. Chronic hepatitis C virus (HCV) infection can since some years be effectively cured with novel direct acting antiviral agents. Thus, it is now possible to study reversal of immunity in patients that are cured from a long-lasting chronic infection. We here highlight recent developments in the analysis of various immune cell populations during and after clearance of HCV infection. Surprisingly, whereas reinvigoration of certain immune traits clearly can be seen, many features of immune exhaustion persist over time after viral elimination. Thus, a long-term chronic insult might result in irreversible damage to our immune system. This will be important to consider in therapeutic vaccination efforts against chronic infection and in the development of immunotherapy based strategies against cancer.

摘要

慢性病毒感染会导致我们的免疫系统恶化。然而,由于持续性感染很少能被清除,因此,耗尽的免疫系统的恢复能力在很大程度上仍然难以捉摸。新型直接作用抗病毒药物已可有效治愈慢性丙型肝炎病毒(HCV)感染。因此,现在可以研究从长期慢性感染中治愈的患者的免疫逆转。我们在此强调了在 HCV 感染清除过程中和清除后分析各种免疫细胞群的最新进展。令人惊讶的是,尽管某些免疫特征的恢复活力显而易见,但在病毒清除后很长一段时间内,免疫衰竭的许多特征仍然存在。因此,长期的慢性损伤可能会对我们的免疫系统造成不可逆转的损害。这对于针对慢性感染的治疗性疫苗接种工作以及针对癌症的免疫治疗策略的发展都很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def7/7578424/42e47f4f1aae/fimmu-11-571166-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def7/7578424/42e47f4f1aae/fimmu-11-571166-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def7/7578424/42e47f4f1aae/fimmu-11-571166-g001.jpg

相似文献

1
Reversal of Immunity After Clearance of Chronic HCV Infection-All Reset?慢性 HCV 感染清除后的免疫逆转——一切重置?
Front Immunol. 2020 Oct 8;11:571166. doi: 10.3389/fimmu.2020.571166. eCollection 2020.
2
Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses.清除丙型肝炎病毒对 HCV 特异性 CD8+ T 细胞反应的功能和线粒体损伤的影响有限。
J Hepatol. 2019 Nov;71(5):889-899. doi: 10.1016/j.jhep.2019.06.025. Epub 2019 Jul 8.
3
Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy.尽管无干扰素治疗成功,但慢性丙型肝炎病毒感染中存在不可逆的黏膜相关恒定T细胞功能障碍。
Eur J Immunol. 2016 Sep;46(9):2204-10. doi: 10.1002/eji.201646447. Epub 2016 Jul 12.
4
Successful direct-acting antiviral therapy improves circulating mucosal-associated invariant T cells in patients with chronic HCV infection.直接作用抗病毒疗法可改善慢性丙型肝炎感染患者的循环黏膜相关不变 T 细胞。
PLoS One. 2020 Dec 31;15(12):e0244112. doi: 10.1371/journal.pone.0244112. eCollection 2020.
5
Reversal of T Cell Exhaustion in Chronic HCV Infection.慢性 HCV 感染中 T 细胞耗竭的逆转。
Viruses. 2020 Jul 25;12(8):799. doi: 10.3390/v12080799.
6
Imprint of unconventional T-cell response in acute hepatitis C persists despite successful early antiviral treatment.尽管早期抗病毒治疗取得成功,但急性丙型肝炎中非常规T细胞反应的印记仍然存在。
Eur J Immunol. 2022 Mar;52(3):472-483. doi: 10.1002/eji.202149457. Epub 2021 Dec 13.
7
Intra-Hepatic Depletion of Mucosal-Associated Invariant T Cells in Hepatitis C Virus-Induced Liver Inflammation.丙型肝炎病毒诱导的肝脏炎症中黏膜相关恒定T细胞的肝内耗竭
Gastroenterology. 2017 Nov;153(5):1392-1403.e2. doi: 10.1053/j.gastro.2017.07.043. Epub 2017 Aug 2.
8
Immunology of hepatitis C virus infections.丙型肝炎病毒感染的免疫学。
Best Pract Res Clin Gastroenterol. 2012 Aug;26(4):391-400. doi: 10.1016/j.bpg.2012.09.005.
9
[Adaptive cell immune response against the hepatitis C virus infection].[针对丙型肝炎病毒感染的适应性细胞免疫反应]
Med Clin (Barc). 2007 Oct 6;129(12):469-76. doi: 10.1157/13111005.
10
MAIT be different-persisting dysfunction after DAA-mediated clearance of chronic hepatitis C virus infection.MAIT 细胞在 DAA 介导的慢性丙型肝炎病毒清除后可能持续功能障碍。
Eur J Immunol. 2016 Sep;46(9):2099-102. doi: 10.1002/eji.201646581.

引用本文的文献

1
Unveiling the nexus between direct-acting antivirals in hepatitis C virus elimination and immune response.揭示丙型肝炎病毒清除中直接作用抗病毒药物与免疫反应之间的联系。
Clin Exp Med. 2025 Jul 30;25(1):269. doi: 10.1007/s10238-025-01811-y.
2
Viral hepatitis moderates the impact of TGFB1 on neurocognitive impairment.病毒肝炎调节 TGFB1 对神经认知障碍的影响。
Kaohsiung J Med Sci. 2024 Sep;40(9):852-861. doi: 10.1002/kjm2.12872. Epub 2024 Jul 6.
3
Autoimmune hepatitis and primary sclerosing cholangitis after direct-acting antiviral treatment for hepatitis C virus: A case report.

本文引用的文献

1
TOX is expressed by exhausted and polyfunctional human effector memory CD8 T cells.TOX 由耗尽和多功能的人效应记忆 CD8 T 细胞表达。
Sci Immunol. 2020 Jul 3;5(49). doi: 10.1126/sciimmunol.aba7918.
2
Adaptive Natural Killer Cell Functional Recovery in Hepatitis C Virus Cured Patients.慢性丙型肝炎病毒治愈患者自然杀伤细胞功能的适应性恢复
Hepatology. 2021 Jan;73(1):79-90. doi: 10.1002/hep.31273. Epub 2020 Nov 2.
3
Plasma FABP4 is associated with liver disease recovery during treatment-induced clearance of chronic HCV infection.
丙型肝炎病毒直接抗病毒治疗后出现自身免疫性肝炎和原发性硬化性胆管炎:一例报告
World J Hepatol. 2024 Feb 27;16(2):286-293. doi: 10.4254/wjh.v16.i2.286.
4
Impending HCC diagnosis in patients with cirrhosis after HCV cure features a natural killer cell signature.在 HCV 治愈后肝硬化患者即将发生 HCC 的诊断特征是自然杀伤细胞特征。
Hepatology. 2024 Jul 1;80(1):202-222. doi: 10.1097/HEP.0000000000000804. Epub 2024 Feb 20.
5
Humoral Immune Response after COVID-19 mRNA Vaccination in Patients with Liver Cirrhosis: A Prospective Real-Life Single Center Study.肝硬化患者接种新冠病毒mRNA疫苗后的体液免疫反应:一项前瞻性真实世界单中心研究
Biomedicines. 2023 Apr 28;11(5):1320. doi: 10.3390/biomedicines11051320.
6
Reversibility of some oxidative stress markers in chronic hepatitis C patients after receiving direct-acting antiviral agents.接受直接抗病毒药物治疗后慢性丙型肝炎患者某些氧化应激标志物的可逆性
J Virus Erad. 2023 Feb 26;9(1):100318. doi: 10.1016/j.jve.2023.100318. eCollection 2023 Mar.
7
Mesenchymal stem cells-based therapy in liver diseases.基于间充质干细胞的肝脏疾病治疗
Mol Biomed. 2022 Jul 27;3(1):23. doi: 10.1186/s43556-022-00088-x.
8
Gamma-Delta T-Cell Phenotype and Function in DAA-Treated HIV-HCV Co-Infected and HCV-Mono-Infected Subjects.DAA 治疗的 HIV-HCV 共感染和 HCV 单感染受试者中的 γδ T 细胞表型和功能。
Viruses. 2022 Jul 22;14(8):1594. doi: 10.3390/v14081594.
9
Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada.加拿大 HIV/HCV 共感染人群中丙型肝炎病毒治愈对抑郁症状的影响。
Clin Infect Dis. 2023 Feb 8;76(3):e702-e709. doi: 10.1093/cid/ciac540.
10
HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients.直接作用抗病毒药物治愈 HCV 可改善 HIV/HCV 合并感染患者的肝脏和免疫标志物。
Front Immunol. 2021 Aug 23;12:723196. doi: 10.3389/fimmu.2021.723196. eCollection 2021.
血浆 FABP4 与慢性 HCV 感染治疗诱导清除期间的肝病恢复相关。
Sci Rep. 2020 Feb 7;10(1):2081. doi: 10.1038/s41598-020-58768-z.
4
MAIT Cells Are Enriched and Highly Functional in Ascites of Patients With Decompensated Liver Cirrhosis.MAIT 细胞在肝功能失代偿的肝硬化患者腹水中富集且功能活跃。
Hepatology. 2020 Oct;72(4):1378-1393. doi: 10.1002/hep.31153. Epub 2020 Oct 13.
5
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection.靶向 p53 和组蛋白甲基转移酶可恢复 HCV 感染中耗竭的 CD8+ T 细胞。
Nat Commun. 2020 Jan 30;11(1):604. doi: 10.1038/s41467-019-14137-7.
6
29-Color Flow Cytometry: Unraveling Human Liver NK Cell Repertoire Diversity.29- 色流式细胞术:揭示人类肝脏自然杀伤细胞受体库多样性。
Front Immunol. 2019 Nov 19;10:2692. doi: 10.3389/fimmu.2019.02692. eCollection 2019.
7
Follicular T helper cells shape the HCV-specific CD4+ T cell repertoire after virus elimination.滤泡辅助性 T 细胞在病毒清除后塑造 HCV 特异性 CD4+ T 细胞库。
J Clin Invest. 2020 Feb 3;130(2):998-1009. doi: 10.1172/JCI129642.
8
Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses.清除丙型肝炎病毒对 HCV 特异性 CD8+ T 细胞反应的功能和线粒体损伤的影响有限。
J Hepatol. 2019 Nov;71(5):889-899. doi: 10.1016/j.jhep.2019.06.025. Epub 2019 Jul 8.
9
Direct antiviral agents upregulate natural killer cell potential activity in chronic hepatitis C patients.直接抗病毒药物上调慢性丙型肝炎患者自然杀伤细胞的潜在活性。
Clin Exp Med. 2019 Aug;19(3):299-308. doi: 10.1007/s10238-019-00564-9. Epub 2019 Jun 20.
10
Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals.丙型肝炎病毒在直接作用抗病毒药物治愈感染后留下表观遗传特征。
PLoS Genet. 2019 Jun 19;15(6):e1008181. doi: 10.1371/journal.pgen.1008181. eCollection 2019 Jun.